BRYANT MAXWELL: Open Payments
NPI 1275005977 · LAKEWOOD RANCH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,239 in 47 payments from 13 companies in 2025. Trend: 2023 $454 · 2024 $550 · 2025 $1,239
Food & beverage: $1,239
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $261 |
| UCB, Inc. | 3 | $181 |
| Janssen Biotech, Inc. | 12 | $170 |
| GENZYME CORPORATION | 4 | $126 |
| Lilly USA, LLC | 1 | $121 |
| Novartis Pharmaceuticals Corporation | 5 | $116 |
| Amgen Inc. | 5 | $103 |
| Galderma Laboratories, L.P. | 3 | $57 |
| PFIZER INC. | 1 | $29 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $21 |
Products named: Bimzelx, TREMFYA, RINVOQ, DUPIXENT, EBGLYSS, SKYRIZI, OTEZLA, COSENTYX.
Industry payments across FL — which companies pay providers there.
